Literature DB >> 17443585

Oxygen therapy during exercise training in chronic obstructive pulmonary disease.

M L Nonoyama1, D Brooks, Y Lacasse, G H Guyatt, R S Goldstein.   

Abstract

BACKGROUND: Exercise training within the context of pulmonary rehabilitation improves outcomes of exercise capacity, dyspnea and health-related quality of life in individuals with chronic obstructive pulmonary disease (COPD). Supplemental oxygen in comparison to placebo increases exercise capacity in patients performing single-assessment exercise tests. The addition of supplemental oxygen during exercise training may enable individuals with COPD to tolerate higher levels of activity with less exertional symptoms, ultimately improving quality of life.
OBJECTIVES: To determine how supplemental oxygen in comparison to control (compressed air or room air) during the exercise-training component of a pulmonary rehabilitation program affects exercise capacity, dyspnea and health-related quality of life in individuals with COPD. SEARCH STRATEGY: All records in the Cochrane Airways Group Specialized Register of trials coded as 'COPD' were searched using the following terms: (oxygen* or O2*) AND (exercis* or train* or rehabilitat* or fitness* or physical* or activ* or endur* or exert* or walk* or cycle*). Searching the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library), MEDLINE, EMBASE and CINAHL databases identified studies. The last search was carried out in June 2006. SELECTION CRITERIA: Only randomized controlled trials (RCTs) comparing oxygen-supplemented exercise training to non-supplemented exercise training (control group) were considered for inclusion. Participants were 18 years or older, diagnosed with COPD and did not meet criteria for long-term oxygen therapy. No studies with mixed populations (pulmonary fibrosis, cystic fibrosis, etc) were included. Exercise training was greater than or equal to three weeks in duration and included a minimum of two sessions a week. DATA COLLECTION AND ANALYSIS: Two review authors independently selected trials for inclusion in the review and extracted data. Weighted mean differences (WMD) with 95% confidence intervals (CI) were calculated using a random-effects model. Missing data were requested from authors of primary studies. MAIN
RESULTS: Five RCTs met the inclusion criteria. The maximum number of studies compared in the meta-analysis was three (31 on oxygen versus 32 control participants), because all included studies did not measure the same outcomes. When two studies were pooled, statistically significant improvements of oxygen-supplemented exercise training were found in constant power exercise time, WMD 2.68 minutes (95% CI 0.07 to 5.28 minutes). Supplemental oxygen increased the average exercise time from 6 to 14 minutes; the control intervention increased average exercise time from 6 to 12 minutes. Constant power exercise end-of-test Borg score (on a scale from 1 to 10) also showed statistically significant improvements with oxygen-supplemented exercise training, WMD -1.22 units (95% CI -2.39 to -0.06). One study showed a significant improvement in the change of Borg score after the shuttle walk test, by -1.46 units (95% CI -2.72 to -0.19). There were no significant differences in maximal exercise outcomes, functional exercise outcomes (six-minute walk test), shuttle walk distance, health-related quality of life or oxygenation status. According to the GRADE system most outcomes were rated as low quality because they were limited by study quality. AUTHORS'
CONCLUSIONS: This review provides little support for oxygen supplementation during exercise training for individuals with COPD, but the evidence is very limited. Studies with larger number of participants and strong design are required to permit strong conclusions, especially for functional outcomes such as symptom alleviation, health-related quality of life and ambulation.

Entities:  

Mesh:

Year:  2007        PMID: 17443585      PMCID: PMC8885311          DOI: 10.1002/14651858.CD005372.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  217 in total

Review 1.  Effects of long-term oxygen therapy on neuropsychiatric function and quality of life.

Authors:  J A Wedzicha
Journal:  Respir Care       Date:  2000-01       Impact factor: 2.258

Review 2.  A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD.

Authors:  Jeroen J W Liesker; Peter J Wijkstra; Nick H T Ten Hacken; Gerard H Koëter; Dirkje S Postma; Huib A M Kerstjens
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

3.  RESPONSES TO EXERCISE TRAINING IN PATIENTS WITH EMPHYSEMA.

Authors:  A K PIERCE; H F TAYLOR; R K ARCHER; W F MILLER
Journal:  Arch Intern Med       Date:  1964-01

4.  The oxygen car (OXCAR) in pulmonary rehabilitation of patients with respiratory failure.

Authors:  M Gimenez; P C Goepfert; J LaCoste
Journal:  Respir Care       Date:  1977-07       Impact factor: 2.258

Review 5.  Effects of long-term oxygen therapy on mortality and morbidity.

Authors:  G J Criner
Journal:  Respir Care       Date:  2000-01       Impact factor: 2.258

Review 6.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

7.  Comparison of three oxygen delivery systems during exercise in hypoxemic patients with chronic obstructive pulmonary disease.

Authors:  E M Hagarty; M S Skorodin; W E Langbein; C I Hultman; J A Jessen; K C Maki
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

Review 8.  Domiciliary oxygen for chronic obstructive pulmonary disease.

Authors:  J M Cranston; A J Crockett; J R Moss; J H Alpers
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

9.  Supplemental oxygen increases arterial stiffness in chronic obstructive pulmonary disease.

Authors:  Matthew N Bartels; Sanja Jelic; Robert C Basner; Pakkay Ngai; John M Gonzalez; Ronald E De Meersman
Journal:  Respir Med       Date:  2004-01       Impact factor: 3.415

10.  Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group.

Authors: 
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391

View more
  21 in total

Review 1.  Updating the evidence-base for suctioning adult patients: a systematic review.

Authors:  Tom J Overend; Cathy M Anderson; Dina Brooks; Lisa Cicutto; Michael Keim; Debra McAuslan; Mika Nonoyama
Journal:  Can Respir J       Date:  2009 May-Jun       Impact factor: 2.409

2.  What Does the Cochrane Collaboration Say about Cardiovascular Training?

Authors: 
Journal:  Physiother Can       Date:  2008-04-15       Impact factor: 1.037

3.  What Does the Cochrane Collaboration Say about Respiratory Physiotherapy?

Authors: 
Journal:  Physiother Can       Date:  2012-04-05       Impact factor: 1.037

4.  Ambulatory Oxygen for Exercise-Induced Desaturation and Dyspnea in Chronic Obstructive Pulmonary Disease (COPD): Systematic Review and Meta-Analysis.

Authors:  Stanley I Ejiofor; Susan Bayliss; Abubacarr Gassamma; Alice M Turner
Journal:  Chronic Obstr Pulm Dis       Date:  2016-01-06

5.  Effects of oxygen on exercise duration in chronic obstructive pulmonary disease patients before and after pulmonary rehabilitation.

Authors:  Nha Voduc; Caroline Tessier; Elham Sabri; Dean Fergusson; Lyne Lavallee; Shawn D Aaron
Journal:  Can Respir J       Date:  2010 Jan-Feb       Impact factor: 2.409

Review 6.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

7.  Clinical features of patients on home oxygen therapy due to chronic respiratory failure at one university hospital.

Authors:  Kyoung Hee Kim; Tae Yun Park; Eun Sun Kim; Keun Bum Chung; Sang-Min Lee; Jae-Joon Yim; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Seok-Chul Yang
Journal:  Korean J Intern Med       Date:  2012-09-01       Impact factor: 2.884

Review 8.  WITHDRAWN: Interventions for fatigue and weight loss in adults with advanced progressive illness.

Authors:  Cathy Payne; Philip J Wiffen; Suzanne Martin
Journal:  Cochrane Database Syst Rev       Date:  2017-04-07

Review 9.  Oxygen therapy in chronic obstructive pulmonary disease.

Authors:  Victor Kim; Joshua O Benditt; Robert A Wise; Amir Sharafkhaneh
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 10.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.

Authors:  Denis E O'Donnell; Shaw Aaron; Jean Bourbeau; Paul Hernandez; Darcy D Marciniuk; Meyer Balter; Gordon Ford; Andre Gervais; Rogers Goldstein; Rick Hodder; Alan Kaplan; Sean Keenan; Yves Lacasse; Francois Maltais; Jeremy Road; Graeme Rocker; Don Sin; Tasmin Sinuff; Nha Voduc
Journal:  Can Respir J       Date:  2007-09       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.